AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Minglip-G 2 Tablet SR

Prescription Icon
Prescription Required

Marketer

Siskan Pharma

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Minglip-G 2 Tablet SR

Diabexe Duo SR tablets are a dual-action antidiabetic medication, combining two active ingredients to manage type 2 diabetes in adults. This medication helps regulate blood glucose levels. Diabexe Duo SR should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continue taking Diabexe Duo SR even if you feel well or your blood sugar is controlled; abrupt cessation without medical consultation risks elevated blood glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is part of a comprehensive diabetes management plan incorporating a balanced diet, regular physical activity, and weight management as recommended by your doctor. Lifestyle choices are crucial in diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect; familiarize yourself with its symptoms (sweating, dizziness, headache, tremors) and appropriate management. Regular meals and carrying a fast-acting glucose source (e.g., sugary snacks or juice) are essential. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Inform your doctor of any history of heart disease before commencing treatment; it may be unsuitable. Pregnant or breastfeeding individuals should consult their doctor before use. Regular blood glucose monitoring and periodic blood tests (blood cell counts and liver function) are recommended.

Uses of Minglip-G 2 Tablet SR

Managing type 2 diabetes

Major Benefits of Minglip-G 2 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Minglip-G 2 Tablet SR. Ingest the tablet whole; do not chew, crush, or fracture it. Consume this medication with food.

Common Side effects of Minglip-G 2 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Minglip-G 2 Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the Minglip-G 2 Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.

How Minglip-G 2 Tablet SR works:

Minglip-G 2 SR tablets contain a dual-action antidiabetic formulation: glimepiride and metformin. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Minglip-G 2 Tablet SR is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Minglip-G 2 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

The extended-release Minglip-G 2 Tablet is contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Minglip-G 2 Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Minglip-G 2 Tablet SR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Minglip-G 2 Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dosage; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Minglip-G 2 Tablet SR :

Should you forget a dose of Minglip-G 2 Tablet SR, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Minglip-G 2 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Minglip-G 2 Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Minglip-G 2 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Minglip-G 2 Tablet SR and seek immediate medical attention.
Minglip-G 2 Tablet SR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication enhances blood glucose control when used with diet and exercise. Glimepiride boosts insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. It's not suitable for type 1 DM.
Minglip-G 2 Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can result in vitamin B12 deficiency.
Prolonged Minglip-G 2 Tablet SR use can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental Vitamin B12 intake is recommended by some researchers.
Minglip-G 2 Tablet SR can indeed cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Minglip-G 2 Tablet SR and alcohol is unsafe. This combination can dangerously lower blood sugar, causing hypoglycemia, and increase the risk of lactic acidosis.
Minglip-G 2 Tablet SR
62
MRP 75
17% off